EDGAR Filing Documents for 9999999995-15-002400

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-15-002400

Accepted

2015-08-31 00:15:16

Documents

Effectiveness Date

2015-08-28

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	597
	Complete submission text file	9999999995-15-002400.txt		2028

Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171

Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)